Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.

V. Bonnefoy (Créteil, France), L. Boyer (Créteil, France), E. Audureau (Créteil, France), L. Bassinet (Créteil, France), S. Zebachi (Créteil, France), B. Douvry (Créteil, France), I. Monnet (Créteil, France), G. Mangiapan (Créteil, France), A. Boudjemaa (Créteil, France), C. Touboul (Créteil, France), L. Ernande (Créteil, France), B. Housset (Créteil, France), B. Maitre (Créteil, France), F. Schlemmer (Créteil, France)

Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Session: Interesting clinical problems for the respiratory physician
Session type: E-poster session
Number: 2724
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Bonnefoy (Créteil, France), L. Boyer (Créteil, France), E. Audureau (Créteil, France), L. Bassinet (Créteil, France), S. Zebachi (Créteil, France), B. Douvry (Créteil, France), I. Monnet (Créteil, France), G. Mangiapan (Créteil, France), A. Boudjemaa (Créteil, France), C. Touboul (Créteil, France), L. Ernande (Créteil, France), B. Housset (Créteil, France), B. Maitre (Créteil, France), F. Schlemmer (Créteil, France). Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.. 2724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010


Retrospective studies of the association between idiopathic pulmonary fibrosis and lifestyle-related disease
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007

Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Body composition and mortality in idiopathic pulmonary fibrosis (IPF): a prospective cohort study.
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Longitudinal decline in FEV1 in an adult non-cystic fibrosis bronchiectasis cohort
Source: Eur Respir J 2007; 30: Suppl. 51, 529s
Year: 2007

Epidemiology and factors associated with overweight in adults with cystic fibrosis: an Italian multicenter experience.
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Year: 2019



Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020



Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013


Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Multicenter feasibility of lung clearance index in preschool children with cystic fibrosis and other lung diseases
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015